Catalent Inc
(MEX:CTLT)
MXN
1020
0 (0%)
Market Cap: 231.55 Bil
Enterprise Value: 324.58 Bil
PE Ratio: 0
PB Ratio: 3.23
GF Score: 81/100 Catalent Inc at Barclays Global Healthcare Conference Transcript
Mar 12, 2019 / 06:35PM GMT
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
Great. Good afternoon, everybody. Thanks for joining us for Catalent's presentation. I'm Jack Meehan, the Barclays' life science tools and diagnostics analyst. Pleased to be joined by our presenter today, CFO Wetteny Joseph. Before we kick it off, we're going to do 3 audience response questions quickly. So use the BlackBerry device in front of you. We'll run through them quick. First, what do you view as Catalent's organic growth profile over the next 3 years?
Wetteny N. Joseph
Catalent, Inc. - Senior VP & CFO
Yes, sure, I'll...
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst
You're not allowed to answer yet. We're going to compare your answers later, towards the audience thing.
Wetteny N. Joseph;Jack Meehan
Catalent, Inc. - Senior VP & CFO;Barclays Bank PLC, Research Division - VP & Senior
Okay, sorry.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot